This article is worth reading several times... In the context of medical insurance cost control, Brii Biosciences has made a wise choice by combining innovation and accessibility under public health issues. Besides the popularity of neutralizing antibodies, I think this is another reason why Brii Biosciences' stock price has significantly outperformed other 18A companies this year. $BRII-B (02137.HK)$